In this review, we discussed different biomarkers related to the efficacy of ICIs and their potential prognostic value in lung cancer (Table 3), including TMB, TILs, IFNγ, NLR, and the composition of the gut microbiota [155]. This evidence concerns the gene IFNG and lung cancer.